bosentan anhydrous has been researched along with Acute Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jian, X; Wang, J; Zhang, W; Zhang, Z; Zhou, Q | 1 |
| Akpinar, E; Albayrak, A; Atmaca, HT; Bayraktutan, Z; Cayir, A; Cayir, Y; Kara, M; Kose, D; Ugan, RA | 1 |
| Bitzinger, DI; Gruber, M; Ittner, KP; Lubnow, M; Nietsch, R; Pawlik, M; Trabold, B | 1 |
3 other study(ies) available for bosentan anhydrous and Acute Lung Injury
| Article | Year |
|---|---|
Using bosentan to treat paraquat poisoning-induced acute lung injury in rats.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Bosentan; Disease Models, Animal; Endothelin-1; Hydroxyproline; Male; Paraquat; Rats; Rats, Wistar; Sulfonamides; Transforming Growth Factor beta1 | 2013 |
The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.
Topics: Acute Lung Injury; Animals; Bosentan; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Glutathione; Lung; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Sulfonamides; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2015 |
Bosentan reduces oxidative burst in acid aspiration-induced lung injury in rats.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bosentan; Hydrochloric Acid; Male; Neutrophils; Pneumonia, Aspiration; Random Allocation; Rats; Rats, Sprague-Dawley; Respiratory Burst; Sulfonamides | 2009 |